BICO Group AB logo

BICO Group AB (BICOs)

Market Closed
CBOE CBOE
- Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
Want to track BICOs and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BICOs is not paying dividends to its shareholders.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.66%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

BICO Group AB (BICOs) FAQ

On which exchange is it traded?

BICO Group AB is listed on CBOE.

What is its stock symbol?

The ticker symbol is BICOs.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has BICO Group AB ever had a stock split?

No, there has never been a stock split.

BICO Group AB Profile

Biotechnology Industry
Healthcare Sector
Maria Forss CEO
CBOE Exchange
SE0013647385 ISIN
SE Country
695 Employees
- Last Dividend
10 Jan 2020 Last Split
- IPO Date

Overview

BICO Group AB (publ) is recognized as a pioneering entity in the bioconvergence industry, demonstrating a broad geographical presence across North America, Europe, Asia, and various global markets. The company's operations are segmented into Bioprinting, Biosciences, and Bioautomation, reflecting its comprehensive approach towards modernizing life sciences and healthcare sectors. Initially established as Cellink AB (publ), the organization underwent a rebranding to BICO Group AB (publ) in August 2021, marking a significant milestone since its inception in 2016. Based in Gothenburg, Sweden, BICO Group is committed to advancing medical, pharmaceutical, and cosmetic industries by integrating cutting-edge technologies and fostering innovation within bioconvergence.

Products and Services

  • Bioprinting

    This segment emphasizes products, solutions, and services dedicated to supporting 3D cell culture and 3D printing technologies. BICO Group's bioprinting offerings are designed to expedite research and development processes, enabling the creation of complex biological structures that can mimic natural tissues, thereby facilitating advancements in tissue engineering and regenerative medicine.

  • Biosciences

    In the Biosciences segment, BICO Group provides a variety of instruments tailored for efficient cell handling, management of rare samples, and seamless transfer of liquids and reagents. The company also supplies platforms for downstream analysis, catering to the needs of researchers and professionals in biotechnological and pharmaceutical sectors. Through these tools, BICO Group aids in streamlining experimental workflows and enhancing the accuracy of scientific investigations.

  • Bioautomation

    The Bioautomation segment offers comprehensive products and services that encompass precision dispensing, advanced sample preparation, multiplex analysis, and assay miniaturization. Additionally, it addresses the needs of the diagnostic and medical device manufacturing industries with solutions that optimize efficiency and reliability in laboratory processes. BICO Group's bioautomation solutions are critical for organizations aiming to achieve high-throughput screening and diagnostic testing with utmost precision.

Contact Information

Address: Arvid Wallgrens Backe 20
Phone: 46 7 08 30 08 90